Inventor · disambiguated record
Wolf Herman Fridman
Also filed as: FRIDMAN WOLF H · FRIDMAN WOLF-HERMAN
13 granted patents·6 pending applications·472 citations·filing 1995–2022
94Inventor score
Files withVERTEX PHARMA10INST NAT SANTE RECH MED5BATCHELOR MARK JAMES2GALON JEROME1LAB FRANCAIS DU FRACTIONNEMENT1
Top patents by PatentIndex Score
19 records- 0194US7790713B2Inhibitors of interleukin-1β converting enzymeVERTEX PHARMA·Filed 2007·Granted Sep 7, 2010·24 cites·20 claims
- 0293US6423840B1Inhibitors of interleukin-1β converting enzymeVERTEX PHARMA·Filed 2001·Granted Jul 23, 2002·40 cites·10 claims
- 0392US6204261B1Inhibitors of interleukin-1β Converting enzyme inhibitorsVERTEX PHARMA·Filed 1996·Granted Mar 20, 2001·80 cites·34 claims
- 0492US5874424AInhibitors of interleukin-1β converting enzymeVERTEX PHARMA·Filed 1996·Granted Feb 23, 1999·141 cites·7 claims
- 0591US8119631B2Inhibitors of interleukin-1β converting enzymeBATCHELOR MARK JAMES·Filed 2010·Granted Feb 21, 2012·24 cites·15 claims
- 0686US8481271B2Vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said methodGALON JEROME·Filed 2006·Granted Jul 9, 2013·13 cites·33 claims
- 0785US10191059B2In vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said methodINST NAT SANTE RECH MED·Filed 2015·Granted Jan 29, 2019·2 cites·10 claims
- 0885US6258948B1Inhibitors of Interleukin-1β converting enzymeVERTEX PHARMA·Filed 1999·Granted Jul 10, 2001·42 cites·46 claims
- 0982US5843904AInhibitors of interleukin-1βconverting enzymeVERTEX PHARMA·Filed 1995·Granted Dec 1, 1998·51 cites·19 claims
- 1078US2022308063A1In Vitro Method for the Prognosis of Progression of a Cancer and of the Outcome in a Patient and Means for Performing Said MethodINST NAT SANTE RECH MED·Filed 2022·Application pending·0 cites
- 1171US6008217AInhibitors of interleukin-1β converting enzymeVERTEX PHARMA·Filed 1995·Granted Dec 28, 1999·37 cites·30 claims
- 1270US11300569B2In vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said methodINST NAT SANTE RECH MED·Filed 2018·Granted Apr 12, 2022·0 cites·12 claims
- 1363US6162790AInhibitors of interleukin-1β converting enzymeVERTEX PHARMA·Filed 1998·Granted Dec 19, 2000·17 cites·16 claims
- 1461US2005143436A1Inhibitors of interleukin-1beta converting enzymeVERTEX PHARMA·Filed 2004·Application pending·0 cites
- 1559US7790399B2Preparation of human, humanized or chimaeric antibodies or polypeptides having different binding profiles to Fcgamma receptorsLAB FRANCAIS DU FRACTIONNEMENT·Filed 2004·Granted Sep 7, 2010·1 cites·13 claims
- 1659US2014057257A1In vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said methodINST NAT SANTE RECH MED·Filed 2013·Application pending·0 cites
- 1754US2003225269A1Inhibitors of interleukin-1beta converting enzymeVERTEX PHARMA·Filed 2002·Application pending·0 cites
- 1847US2024229154A9Method for prognosis and treating a patient suffering from cancerINST NAT SANTE RECH MED·Filed 2022·Application pending·0 cites
- 1937US2012165319A1Inhibitors of interleukin-1 beta converting enzymeBATCHELOR MARK JAMES·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Wolf Herman Fridman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →